Invention Grant
- Patent Title: Bipyrazole derivatives as JAK inhibitors
-
Application No.: US17229397Application Date: 2021-04-13
-
Publication No.: US11591318B2Publication Date: 2023-02-28
- Inventor: Yun-Long Li , Jincong Zhuo , Ding-Quan Qian , Song Mei , Ganfeng Cao , Yongchun Pan , Qun Li , Zhongjiang Jia
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61P37/06
Abstract:
The present invention provides compounds of Formula I: or pharmaceutically acceptable salts thereof, as well as their compositions and methods of use, that inhibit the activity of Janus kinase (JAK) and are useful in the treatment of diseases related to the activity of JAK including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Public/Granted literature
- US20210238168A1 BIPYRAZOLE DERIVATIVES AS JAK INHIBITORS Public/Granted day:2021-08-05
Information query
